Patton Fund Management Inc. has made a notable move by purchasing 10,132 shares of Moderna, Inc., valued at about $280,000. According to a recent SEC filing, this acquisition took place in the second quarter and aligns with similar investments by other hedge funds.

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) has seen its projected earnings for 2026 revised downward. According to Leerink Partnrs’ recent report, the biotech company’s EPS forecast now stands at ($4.05) for fiscal year 2026.

Woodline Partners LP has boosted its investment in CG Oncology (NASDAQ:CGON) by 21.5% during the first quarter. After purchasing an additional 135,472 shares, the firm now holds 764,357 shares worth $18,719,000, signaling a notable show of confidence in the biotech company’s future.